Mainz Biomed N.V.
MYNZ
$4.37
-$0.365-7.72%
| 12/31/2023 | 06/30/2023 | 12/31/2022 | 09/30/2021 | 03/31/2021 | |
|---|---|---|---|---|---|
| Net Income | -5.18M | -8.25M | -8.19M | -5.71M | -40.00K |
| Total Depreciation and Amortization | 204.50K | 171.00K | 244.50K | 17.50K | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 88.60K | 1.18M | 1.61M | 4.22M | -- |
| Change in Net Operating Assets | 235.10K | 1.78M | 1.62M | -68.60K | 40.00K |
| Cash from Operations | -4.66M | -5.12M | -4.71M | -1.54M | 0.00 |
| Capital Expenditure | -161.80K | -123.60K | -14.80K | -6.10K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 609.90K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00K | 0.00 | -- | -- | -- |
| Cash from Investing | -261.80K | -123.60K | -14.80K | 603.90K | -- |
| Total Debt Issued | 0.00 | 5.06M | -- | 2.80K | -- |
| Total Debt Repaid | -1.03M | -252.30K | -109.50K | -18.60K | -- |
| Issuance of Common Stock | 4.50M | 611.40K | -- | 5.21M | -- |
| Repurchase of Common Stock | -- | -- | 0.00 | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.47M | 5.42M | -109.50K | 5.20M | -- |
| Foreign Exchange rate Adjustments | -798.30K | -123.80K | -28.10K | 9.50K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.25M | 52.90K | -4.86M | 4.27M | -- |
